Masaki Morishita

Dr. Masaki Morishita

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
TITakafumi Imai
Takafumi Imai
YTYuki Takahashi
Yuki Takahashi
MNMakiya Nishikawa
Makiya Nishikawa
KKKana Kato
Kana Kato
MMMasaki Morishita
Masaki Morishita
Yoshinobu TakakuraYoshinobu Takakura
Yoshinobu Takakura
Previous studies using B16BL6‐derived exosomes labelled with gLuc–lactadherin (gLuc‐LA), a fusion protein of Gaussia luciferase (a reporter protein) and lactadherin (an exosome‐tropic protein), showed that the exosomes quickly disappeared from the systemic circulation after intravenous injection in mice. In the present study, the mechanism of rapid clearance of intravenously injected B16BL6 exosomes was investigated. gLuc‐LA‐labelled exosomes were obtained from supernatant of B16BL6 cells after transfection with a plasmid DNA encoding gLuc‐LA. Labelling was stable when the exosomes were incubated in serum. By using B16BL6 exosomes labelled with PKH26, a lipophilic fluorescent dye, it was demonstrated that PKH26‐labelled B16BL6 exosomes were taken up by macrophages in the liver and spleen but not in the lung, while PKH26‐labelled exosomes were taken up by the endothelial cells in the lung. Subsequently, gLuc‐LA‐labelled B16BL6 exosomes were injected into macrophage‐depleted mice prepared by injection with clodronate‐containing liposomes. The clearance of the intravenously injected B16BL6 exosomes from the blood circulation was much slower in macrophage‐depleted mice than that in untreated mice. These results indicate that macrophages play important roles in the clearance of intravenously injected B16BL6 exosomes from the systemic circulation.

1 December 2016 in Biomaterials
Verified
Journal Article
Closed access
MMMasaki Morishita
Masaki Morishita
YTYuki Takahashi
Yuki Takahashi
AMAkihiro Matsumoto
Akihiro Matsumoto
MNMakiya Nishikawa
Makiya Nishikawa
YTYoshinobu Takakura
Yoshinobu Takakura

1 February 2015 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
MMMasaki Morishita
Masaki Morishita
YTYuki Takahashi
Yuki Takahashi
MNMakiya Nishikawa
Makiya Nishikawa
KSKohei Sano
Kohei Sano
KKKana Kato
Kana Kato
Yoshinobu TakakuraYoshinobu Takakura
Yoshinobu Takakura

1 January 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
CCChonlada Charoenviriyakul
Chonlada Charoenviriyakul
YTYuki Takahashi
Yuki Takahashi
MMMasaki Morishita
Masaki Morishita
AMAkihiro Matsumoto
Akihiro Matsumoto
MNMakiya Nishikawa
Makiya Nishikawa
YTYoshinobu Takakura
Yoshinobu Takakura

1 January 2017 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AMAkihiro Matsumoto
Akihiro Matsumoto
YTYuki Takahashi
Yuki Takahashi
MNMakiya Nishikawa
Makiya Nishikawa
KSKohei Sano
Kohei Sano
MMMasaki Morishita
Masaki Morishita
YTYoshinobu Takakura
Yoshinobu Takakura

1 September 2017 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MMMasaki Morishita
Masaki Morishita
YTYuki Takahashi
Yuki Takahashi
MNMakiya Nishikawa
Makiya Nishikawa
YTYoshinobu Takakura
Yoshinobu Takakura